Department of Clinical Laboratory, Second Affiliated Hospital of Dalian Medical University, Dalian 116023, P.R. China.
Mol Med Rep. 2013 Aug;8(2):655-61. doi: 10.3892/mmr.2013.1527. Epub 2013 Jun 17.
The aim of the present study was to determine the molecular mechanism by which the hepatocyte growth factor (HGF) receptor (cMet) regulates lymphatic metastasis in hepatocellular carcinoma. Mouse hepatoma ascites cell lines with different lymph node metastatic potentials, Hca‑F (high metastatic potential) and Hca‑P (low metastatic potential), were cultured in vitro. Cells were treated with HGF, fibronectin (FN) and laminin (LN), and the phosphorylated tyrosine residues of cMet and the activities of intracellular phospholipase Cγ/diacylglycerol/protein kinase C (PLCγ/DAG/PKC) and phosphoinositol‑3‑kinase/protein kinase B (PI3K/AKT) signaling pathways were analyzed comparatively in the two cell lines using western blot analysis and migration assays. Following HGF treatment, the phosphorylation of cMet at Tyr 1313 and 1365 in Hca‑F cells was higher, while the phosphorylation of cMet at Tyr 1349 was lower than that in Hca‑P. The activity of PLCγ/DAG/PKC was increased in Hca‑F cells compared with Hca‑P cells, whereas the activity of PI3K/AKT was reduced. After FN treatment, the phosphorylation of cMet at Tyr 1313 and the activity of the PLCγ/DAG/PKC signaling pathway was increased in Hca‑F cells compared with Hca‑P cells. Following LN treatment, the phosphorylation of cMet at Tyr 1365 and the activity of PLCγ/DAG/PKC was higher in Hca‑F cells than in Hca‑P cells. Results of the current study indicate that a number of ligands stimulate the phosphorylation of cMet at various tyrosine residues, activating different signaling transduction pathways. In addition, the same ligand was observed to phosphorylate different tyrosine residues on cMet in the two cell lines, as well as activate different intracellular signaling transduction pathways. After cMet is activated, various tyrosine residues are phosphorylated, leading to the activation of the PI3K/AKT and PLCγ/DAG/PKC signaling pathways to different extents in the two cells lines. These results may be important in determining the lymph node metastatic potentials of the two cell lines.
本研究旨在确定肝细胞生长因子(HGF)受体(cMet)通过何种分子机制调节肝癌的淋巴转移。体外培养具有不同淋巴结转移潜能的小鼠肝癌腹水细胞系 Hca-F(高转移潜能)和 Hca-P(低转移潜能)。用 HGF、纤连蛋白(FN)和层粘连蛋白(LN)处理细胞,比较分析两种细胞系中 cMet 磷酸化酪氨酸残基和细胞内磷脂酶 Cγ/二酰基甘油/蛋白激酶 C(PLCγ/DAG/PKC)和磷酸肌醇 3-激酶/蛋白激酶 B(PI3K/AKT)信号通路的活性。HGF 处理后,Hca-F 细胞中 cMet 的 Tyr1313 和 Tyr1365 磷酸化水平较高,而 Tyr1349 磷酸化水平较低。与 Hca-P 细胞相比,Hca-F 细胞中 PLCγ/DAG/PKC 的活性增加,而 PI3K/AKT 的活性降低。FN 处理后,Hca-F 细胞中 cMet 的 Tyr1313 磷酸化和 PLCγ/DAG/PKC 信号通路的活性均高于 Hca-P 细胞。LN 处理后,Hca-F 细胞中 cMet 的 Tyr1365 磷酸化和 PLCγ/DAG/PKC 的活性均高于 Hca-P 细胞。本研究结果表明,多种配体刺激 cMet 在不同酪氨酸残基上的磷酸化,激活不同的信号转导通路。此外,还观察到同一配体在两种细胞系中磷酸化 cMet 的不同酪氨酸残基,并激活不同的细胞内信号转导通路。cMet 激活后,不同的酪氨酸残基发生磷酸化,导致两种细胞系中 PI3K/AKT 和 PLCγ/DAG/PKC 信号通路的激活程度不同。这些结果可能对确定两种细胞系的淋巴结转移潜能具有重要意义。